Cargando...
A Holy Grail of asthma management: toward understanding how long-acting β(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids
There is unequivocal evidence that the combination of an inhaled corticosteroid (ICS)—i.e. glucocorticoid—and an inhaled long-acting β(2)-adrenoceptor agonist (LABA) is superior to each component administered as a monotherapy alone in the clinical management of asthma. Moreover, Calverley and collea...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Publishing Group
2007
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2275445/ https://ncbi.nlm.nih.gov/pubmed/18071293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0707627 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|